Cryoglobulinemic vasculitis in patients with viral hepatitis C. Does viral eradication always lead to a complete clinical and immunological response?

Ashime Sh. Asanova , Elena I. Stilidi , Ruslan R. Ibraimov , Georgiy S. Merezko , Valeriya V. Balakovskaya , Milena M. Ayvazyan , Bulat V. Kabirov , Ramil R. Mutigullin

For citation:

Abstract

Mixed cryoglobulinemiа is one of the common extrahepatic manifestations of chronic viral hepatitis C. According to the research results, about 53% of HCV patients have cryoglobulins in their blood serum. This article analyzes the results of scientific papers by a number of authors who have studied the effectiveness of antiviral treatment in patients with cryoglobulinemia. The purpose of the article is to reveal a number of questions: is there a link between the presence of mixed cryoglobulinemia and liver fibrosis in patients? Will virus eradication always lead to a complete clinical and immunological response? The authors concluded that the presence of mixed cryoglobulinemia is associated with severe liver fibrosis (F3 and F4), which may allow cryoglobulinemia to be considered an immunological indicator of cirrhosis. Diagnostic alertness for patients should be maintained even after achieving a sustained virological response, since a complete immunological response.
Keywords: cryoglobulinemia, cryoglobulinemic vasculitis, chronic viral hepatitis C, antiviral therapy.

References

1. Вирусные гепатиты в Российской Федерации. Аналитический обзор. 11-й выпуск. Под ред. В.И. Покровского, А.А. Тотоляна. СПб.: ФБУН «Санкт-Петербургский НИИЭМ им. Пастера», 2018.
Viral hepatitis in the Russian Federation. Analytical review. 11th issue. Ed. V.I. Pokrovsky, A.A. Totolyan. St. Petersburg: St. Petersburg Scientific Research Institute of Epidemiology and Microbiology named after Pasteur, 2018 (in Russian).
2. Секреты ревматологии. Под ред. В. Стерлинга. СПб., 2001.
Secrets of rheumatology. Ed. V. Sterling, St. Petersburg, 2001 (in Rus-sian).
3. Ghetie D, Mehraban N, Sibley CH. Cold hard facts of cryoglobulinemia: updates on clinical features and treatment advances. Rheum Dis Clin North Am 2015;41(1):93-108. DOI: 10.1016/j.rdc.2014.09.008
4. Dammacco F, Racanelli V, Russi S, Sansonno D. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clin Exp Med 2016;16(3):233-42. DOI: 10.1007/s10238- 016-0410-9
5. Семенкова Е.Н. Системные некротизирующие васкулиты. Русский врач. 2001.
Semenkova E.N. Systemic necrotizing vasculitis. The Russian doctor. 2001 (in Russian).
6. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L. Cryoglobulinemia vasculitis. Current opinion in rheumatology 2002;14(1):29-35.
7. Dammacco F, Lauletta G, Russi S et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med 2019;19(1):1-21. DOI: 10.1007/s10238-018-0536-z
8. Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25(5):1237-44. DOI: 10.1002/hep.510250529
9. Batsaikhan B, Huang CI, Yeh ML et al. Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients. J Gastroenterol Hepatol 2018;33(11):1897-903. DOI: 10.1111/jgh.14275
10. Comarmond C, Cacoub P, Saadoun D. Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals. Therapeutic Advances in Gastroenterology 2020;13.
11. Saadoun D, Resche Rigon M, Pol S et al. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis. J Hepatol 2015;62(1):24-30. DOI: 10.1016/j.jhep.2014.08.015
12. Sise ME, Bloom AK, Wisocky J et al. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology 2016;63(2):408-17. DOI: 10.1002/hep.28297
13. Sollima S, Milazzo L, Vassalini P et al. Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection. Clin Exp Reumatol 2018;111(2):161-2. PMID: 29185964.
14. Милованова С.Ю., Козловская (Лысенко) Л.В., Милованова Л.Ю. и др. Терапия препаратами прямого противовирусного действия HCV-ассоциированного криоглобулинемического васкулита. Всегда ли эрадикация вируса ведет к достижению полного клинического и иммунологического ответа? Доказательная гастроэнтерология. 2024;13(3):26-33.
Milovanova S.Yu., Kozlovskaya (Lysenko) L.V., Milovanova L.Yu. et al. Therapy with drugs of direct antiviral action of HCV-associated cryoglobulinemic vasculitis. Does virus eradication always lead to a complete clinical and immunological response? Evidence-based gastroenterology. 2024;13(3):26-33 (in Russian).
15. Мухин Н.А., Козловская Л.В., Милованова Л.Ю. и др. HCV-ассоциированный криоглобулинемический васкулит с тяжелым поражением почек и развитием В-клеточной лимфомы. Современные возможности изменения прогноза с помощью моноклональных антител к CD20 и противовирусной терапии. Клиническая нефрология. 2011;2;61-9.
Mukhin N.A., Kozlovskaya L.V., Milovanova L.Yu. et al. HCV-associated cryoglobulinemic vasculitis with severe kidney damage and the development of B-cell lymphoma. Modern possibilities of changing the prognosis using monoclonal antibodies to CD20 and antiviral therapy. Clinical nephrology. 2011;2;61-9 (in Russian).

Портал CON-MED.RU:
https://con-med.ru/magazines/klinicheskiy_razbor_v_obshchey_meditsine/klinicheskiy_razbor_v_obshchey_meditsine-03-2025/smeshannaya_krioglobulinemiya_u_patsientov_s_virusnym_gepatitom_c_vsegda_li_eradikatsiya_virusa_vede/

For citation: Asanova A.Sh., Stilidi E.I., Ibraimov R.R., Merezko G.S., Balakovskaya V.V., Ayvazyan M.M., Kabirov B.V., Mutigullin R.R. Cryoglobulinemic vasculitis in patients with viral hepatitis C. Does viral eradication always lead to a complete clinical and immunological response? Clinical review for general practice. 2025; 6 (3): 72–75 (In Russ.). DOI: 10.47407/kr2025.6.03.00p4528

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice